Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated
Clinical trial NCT05433272 · UNKNOWN
Trial details
- NCT number
- NCT05433272
- Sponsor
- Sinovac Biotech (Colombia) S.A.S.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2023-09-10
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.